Continuous Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux
Joseph L. Mathew(Evidence Based Research (United States)), Neha Bhandari, Jitendra Meena(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), A Vasudev
Cited by 1
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000–17
|The Lancet|2020|225
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176